MELTZER LESLIE
SEC insider (Form 3/4/5 filer). CIK 0002084030. Chief Research and Development at Apellis Pharmaceuticals, Inc. (APLS). 9 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.
Companies MELTZER LESLIE has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Officer, Chief Research and Development
MELTZER LESLIE
CIK: 0002084030
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apellis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferDirect107K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect22.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect22.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect45.2K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect45.2K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect61.8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect45.2K shares- - Jan 28, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect45.2K shares- - Aug 26, 2025APLS
Apellis Pharmaceuticals, Inc.
AwardDirect61.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 107,024 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 22,610 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 22,610 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 45,220 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 45,220 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 61,804 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 45,220 | - | $0 | Direct |
| Jan 28, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 45,220 | - | $0 | Direct |
| Aug 26, 2025 | APLS Apellis Pharmaceuticals, Inc. | Award | 61,804 | - | - | Direct |
1-9 of 9 transactions